Peter Amersdorfer
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 2%
- Neurology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cellular and Molecular Neuroscience top 5%
- Co-authors
- James D. MarksGábor MéhesSebastian MannweilerTheresa J. SmithRobert E. SheridanSlave TrajanoskiDavid KingJonathan Terrett
- Topics
- Monoclonal and Polyclonal Antibodies Research (8 papers)Botulinum Toxin and Related Neurological Disorders (5 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- United StatesAustriaHungary
In The Last Decade
Peter Amersdorfer
14 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 821
- Radiology, Nuclear Medicine and Imaging 797
- Neurology 367
- Pulmonary and Respiratory Medicine 300
- Cellular and Molecular Neuroscience 287
Countries citing papers authored by Peter Amersdorfer
This map shows the geographic impact of Peter Amersdorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Amersdorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Amersdorfer more than expected).
Fields of papers citing papers by Peter Amersdorfer
This network shows the impact of papers produced by Peter Amersdorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Amersdorfer. The network helps show where Peter Amersdorfer may publish in the future.
Co-authorship network of co-authors of Peter Amersdorfer
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Amersdorfer. A scholar is included among the top collaborators of Peter Amersdorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Amersdorfer. Peter Amersdorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 33 | |
| 4 | 297 | |
| 5 | 51 | |
| 6 | 15 | |
| 7 | 12 | |
| 8 | 79 | |
| 9 | 268 | |
| 10 | 105 | |
| 11 | 11 | |
| 12 | 165 | |
| 13 | 356 | |
| 14 | 86 | |
| 15 | 56 |
About Peter Amersdorfer
Peter Amersdorfer is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (797 citations), Neurology (367 citations) and Cellular and Molecular Neuroscience (287 citations). Peter Amersdorfer has collaborated with scholars based in United States, Austria and Hungary. Frequent co-authors include James D. Marks, Gábor Méhes, Sebastian Mannweiler, Theresa J. Smith, Robert E. Sheridan, Slave Trajanoski, David King, Jonathan Terrett, Cindy Wong and Ricarda Finnern. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.